Results 11 to 20 of about 19,293 (297)

Paclitaxel as HIPEC-Drug after Surgical Cytoreduction for Ovarian Peritoneal Metastases: A Randomized Phase III Clinical Trial (HIPECOVA)

Current Oncology
Multidisciplinary strategies have transformed the management of advanced ovarian cancer. We aimed to evaluate the effectiveness of paclitaxel in hyperthermic intraperitoneal chemotherapy (HIPEC) following surgical cytoreduction for ovarian peritoneal ...
Pedro Villarejo Campos, Susana Sánchez García, Mariano Amo-Salas, Esther García Santos, Carlos López de la Manzanara, Ana Alberca, David Padilla-Valverde, Francisco Javier Redondo Calvo, Jesús Martín   +8 more
doaj   +2 more sources

Hyperthermic intraperitoneal chemotherapy (HIPEC) plus systemic chemotherapy versus systemic chemotherapy alone in locally advanced gastric cancer after D2 radical resection: a randomized controlled study [PDF]

Journal of Cancer Research and Clinical Oncology, 2023
Currently, there is a lack of an effective strategy for the prevention of peritoneal metastasis (PM) from locally advanced gastric cancer (AGC). This randomized-controlled study aimed to evaluate the outcome of D2 radical resection with hyperthermic ...
Pengfei Yu, Xingmao Huang, Ling Huang, Gaiguo Dai, Qi Xu, Jingquan Fang, Zeyao Ye, Tengjiao Chai, Yian Du   +8 more
openalex   +2 more sources

Prophylactic HIPEC with radical D2 gastrectomy improves survival and peritoneal recurrence rates for locally advanced gastric cancer: personal experience from a randomized case control study

BMC Cancer, 2019
Background To investigate the implications of prophylactic intraoperative Hyperthermic Intraperitoneal Chemotherapy (HIPEC) with D2 radical gastrectomy for locally advanced Gastric Cancer (AGC) in a randomized case control study.
Maneesh Kumarsing Beeharry, Zheng-Lun Zhu, Wen-Tao Liu, Xue-Xin Yao, Min Yan, Zheng-Gang Zhu   +5 more
doaj   +2 more sources

Repeated Cytoreduction Combined with Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Selected Patients Affected by Peritoneal Metastases: Italian PSM Oncoteam Evidence [PDF]

Cancers, 2023
Simple Summary Iterative cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with peritoneal metastases remain controversial regarding safety and efficacy.
Enrico Maria Pasqual, Ambrogio P. Londero, Manuela Robella, Marco Tonello, Antonio Sommariva, Michele De Simone, Stefano Bacchetti, Gian Luca Baiocchi, Salvatore Asero, Federico Coccolini, Franco De Cian, Marcello Guagliò, Armando Cinquegrana, Carola Cenzi, Stefano Scaringi, Antonio Macrì   +15 more
openalex   +2 more sources

Sodium thiosulfate protects from renal impairement following hyperthermic intraperitoneal chemotherapy (HIPEC) with Cisplatin

International Journal of Hyperthermia, 2020
Background Cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy (HIPEC) has been shown to provide benefits in the management of peritoneal metastasis.
N. Laplace, V. Kepenekian, A. Friggeri, O. Vassal, F. Ranchon, C. Rioufol, W. Gertych, L. Villeneuve, O. Glehen, N. Bakrin   +9 more
doaj   +2 more sources

Survival advantage of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) for advanced gastric cancer: experience from a Western tertiary referral center [PDF]

Langenbeck's archives of surgery (Print), 2021
Selection criteria and prognostic factors for patients with advanced gastric cancer (AGC) undergoing cytoreductive surgery (CRS) plus hyperthermic intra-operative peritoneal chemotherapy (HIPEC) have not been well defined and the literature data are not ...
Fausto Rosa, Federica Galiandro, Riccardo Ricci, Dario Di Miceli, Fabio Longo, Giuseppe Quero, Antonio Pio Tortorelli, Sergio Alfieri   +7 more
openalex   +2 more sources

2022 Peritoneal Surface Oncology Group International Consensus on HIPEC Regimens for Peritoneal Malignancies: Colorectal Cancer

Annals of Surgical Oncology, 2023
Background Selected patients with peritoneal metastases of colorectal cancer (PM-CRC) can benefit from potentially curative cytoreductive surgery (CRS) ± hyperthermic intraperitoneal chemotherapy (HIPEC), with a median overall survival (OS) of more than ...
Martin Hübner, K. van der Speeten, K. Govaerts, I. D. de Hingh, L. Villeneuve, S. Kusamura, O. Glehen   +6 more
semanticscholar   +1 more source

Hyperthermic Intraperitoneal Chemotherapy (HIPEC): New Approaches and Controversies on the Treatment of Advanced Epithelial Ovarian Cancer—Systematic Review and Meta-Analysis

Journal of Clinical Medicine, 2023
Background: Hyperthermic intraperitoneal chemotherapy (HIPEC) after cytoreductive surgery has been extensively studied in patients with peritoneal carcinomatosis, and it holds promise as a therapeutic strategy, but its role remains elusive.
L. Della Corte, Carmine Conte, M. Palumbo, Serena Guerra, Dario Colacurci, G. Riemma, Pasquale De Franciscis, P. Giampaolino, A. Fagotti, Giuseppe Bifulco, G. Scambia   +10 more
semanticscholar   +1 more source

Enhanced Recovery after Surgery (ERAS) Program for Patients with Peritoneal Surface Malignancies Undergoing Cytoreductive Surgery with or without HIPEC: A Systematic Review and a Meta-Analysis

Cancers, 2023
Simple Summary Cytoreductive surgery and Hyperthermic IntraPEritoneal Chemotherapy (HIPEC) represent a promising treatment strategy for the management of selected cases of peritoneal cancer, but it’s still burdened by significant morbidity and prolonged ...
M. Robella, M. Tonello, P. Berchialla, V. Sciannameo, Alba Ilari Civit, A. Sommariva, C. Sassaroli, A. di Giorgio, R. Gelmini, V. Ghirardi, F. Roviello, F. Carboni, P. Lippolis, S. Kusamura, M. Vaira   +14 more
semanticscholar   +1 more source

Current Evidence for the Use of HIPEC and Cytoreductive Surgery in Gastric Cancer Metastatic to the Peritoneum

Journal of Clinical Medicine, 2023
Simple Summary Advanced gastric cancer (GCa) is associated with poor prognosis due to the challenge of peritoneal disease, the most common site of metastasis at initial diagnosis, staging laparoscopy, and recurrence.
Anish J Jain, B. Badgwell
semanticscholar   +1 more source